Rajmonda Fjerza
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Is pharmacological thromboprophylaxis necessary in persons with haemophilia undergoing major orthopaedic surgery?
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 27, 2024
Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience.
Journal: Journal of clinical medicine
Published: February 22, 2023
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.
Journal: American journal of hematology
Published: October 18, 2016
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
Journal: American journal of hematology
Published: May 17, 2016
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study.
Journal: Drug design, development and therapy
Published: June 02, 2015
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.
Journal: Blood
Published: July 20, 2014
Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.
Journal: Platelets
Published: June 01, 2012
Patients with ≥ 20 × 10(9)/l platelets at baseline may have a prompt response to romiplostim during the early phase of treatment: an italian single-institution experience.
Journal: Mediterranean journal of hematology and infectious diseases
Published: May 09, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026